During the progression of AML, HMGB1 is secreted to induce TNF-α production and subsequent secretion of IL-1β, which stimulates endothelial cells to release stem cell factor (SCF), which can further promote the proliferation of AML cells. Here, IL1B is linked to acute myeloid leukemia.